10q10k10q10k.net
Arcadia Biosciences, Inc.

Arcadia Biosciences, Inc.RKDAEarnings & Financial Report

Nasdaq

Arcadia Biosciences is a publicly traded American agricultural biotechnology headquartered in Davis, California focused on the development of traits to enhance crop quality and productivity. The company is partly owned by Moral Compass Corporation.

RKDA Q3 2025 Key Financial Metrics

Revenue

$1.3M

Gross Profit

$418.0K

Operating Profit

$-1.2M

Net Profit

$856.0K

Gross Margin

32.1%

Operating Margin

-88.5%

Net Margin

65.7%

YoY Growth

-15.3%

EPS

$0.62

Financial Flow

Arcadia Biosciences, Inc. Q3 2025 Financial Summary

Arcadia Biosciences, Inc. reported revenue of $1.3M for Q3 2025, with a net profit of $856.0K (65.7% margin). Cost of goods sold was $884.0K, operating expenses totaled $1.6M.

Key Financial Metrics

Total Revenue$1.3M
Net Profit$856.0K
Gross Margin32.1%
Operating Margin-88.5%
Report PeriodQ3 2025

Arcadia Biosciences, Inc. Annual Revenue by Year

Arcadia Biosciences, Inc. annual revenue history includes year-by-year totals (for example, 2024 revenue was $5.0M).

YearAnnual Revenue
2024$5.0M
2023$5.3M
2022$10.0M

Income Statement

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Revenue$835000$1.3M$1.3M$1.5M$947000$1.2M$1.5M$1.3M
YoY Growth-16.5%-16.8%-6.0%-3.8%13.4%-4.4%11.4%-15.3%

Balance Sheet

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Assets$19.7M$16.0M$17.4M$15.2M$13.5M$13.0M$7.8M$8.6M
Liabilities$7.0M$5.6M$5.8M$5.1M$7.3M$4.1M$3.3M$3.1M
Equity$12.8M$10.6M$11.7M$10.3M$6.2M$8.9M$4.5M$5.4M

Cash Flow

Q4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025
Operating CF$-4.1M$-3.2M$-2.5M$-1.8M$-2.2M$-1.6M$-2.0M$-257000